Fresenius Medical Care | FME - Ebitda



Fresenius Medical Care reported EUR871M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Akzo Nobel EUR 393M 35M Jun/2025
Alcon AG USD 250M 213M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Beiersdorf EUR 837M 163M Dec/2024
DaVita Healthcare Partners USD 725.7M 127.86M Jun/2025
Demant DKK 2.59B 473M Jun/2025
E.ON EUR 2.22B 219M Jun/2025
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 828M 88M Jun/2025
Fresenius Medical Care EUR 871M 282M Jun/2025
Genmab DKK 376M 172M Jun/2025
Getinge SEK 3.47B 2.13B Dec/2024
Givaudan CHF 910M 196M Jun/2024
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GN Store Nord DKK 639M 42M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 139M Dec/2024
Merck EUR 1.46B 45M Jun/2025
Novartis USD 6.17B 339M Jun/2025
Philips EUR 747M 174M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
RWE EUR 832M 518M Jun/2025
Sanofi EUR 1.89B 971M Jun/2025
SAP EUR 2.89B 83M Jun/2025
Smith & Nephew USD 796M 48.8M Jun/2025